SCATTURIN, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 4.493
AS - Asia 2.223
EU - Europa 1.535
SA - Sud America 326
AF - Africa 30
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 8.621
Nazione #
US - Stati Uniti d'America 4.403
SG - Singapore 856
CN - Cina 728
UA - Ucraina 351
IT - Italia 278
BR - Brasile 262
DE - Germania 236
HK - Hong Kong 232
GB - Regno Unito 188
TR - Turchia 180
SE - Svezia 136
VN - Vietnam 117
FR - Francia 82
FI - Finlandia 81
RU - Federazione Russa 63
MX - Messico 44
CA - Canada 40
AR - Argentina 32
IN - India 26
NL - Olanda 18
ES - Italia 17
JP - Giappone 17
ZA - Sudafrica 17
PL - Polonia 16
BE - Belgio 15
LT - Lituania 14
AT - Austria 12
BD - Bangladesh 11
CZ - Repubblica Ceca 10
IQ - Iraq 9
EC - Ecuador 8
ID - Indonesia 8
NZ - Nuova Zelanda 8
IL - Israele 6
IR - Iran 6
UZ - Uzbekistan 6
CO - Colombia 5
PY - Paraguay 5
VE - Venezuela 5
BG - Bulgaria 4
CL - Cile 4
AE - Emirati Arabi Uniti 3
HU - Ungheria 3
MA - Marocco 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
DZ - Algeria 2
GY - Guiana 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IE - Irlanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
ME - Montenegro 1
MK - Macedonia 1
MY - Malesia 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.621
Città #
Woodbridge 501
Singapore 498
Fairfield 376
Jacksonville 350
Ashburn 327
Chandler 321
Houston 276
Santa Clara 273
Beijing 254
Hong Kong 231
Ann Arbor 213
Wilmington 142
Cambridge 119
Seattle 119
Izmir 115
Nanjing 111
New York 94
Los Angeles 70
Princeton 65
Boardman 55
Ho Chi Minh City 43
San Diego 43
Dallas 42
Munich 41
Addison 39
Nanchang 35
Milan 32
Hanoi 31
Hefei 30
Shanghai 28
Shenyang 28
Hebei 27
Mexico City 25
Tianjin 24
San Mateo 22
São Paulo 22
The Dalles 21
Changsha 20
Rome 18
Chicago 16
Rio de Janeiro 16
Bremen 15
Brussels 15
Dearborn 15
Frankfurt am Main 15
London 15
Tokyo 15
Brooklyn 14
Falls Church 14
Philadelphia 14
Falkenstein 13
Auburn Hills 12
Denver 12
Kunming 12
Montreal 12
Turku 12
Warsaw 12
Buffalo 11
Jiaxing 11
Johannesburg 11
Moscow 11
Norwalk 11
San Francisco 11
Chennai 10
Jinan 10
Orem 10
Toronto 10
Vienna 10
Ankara 9
Ferrara 9
Atlanta 8
Biên Hòa 8
Boston 8
Mountain View 8
Poplar 8
Redwood City 8
Augusta 7
Curitiba 7
Manchester 7
Olomouc 7
Verona 7
Ardabil 6
Auckland 6
Charlotte 6
Helsinki 6
Stockholm 6
Tappahannock 6
Bologna 5
Brasília 5
Caivano 5
Lanzhou 5
New Delhi 5
Ningbo 5
Phoenix 5
Salt Lake City 5
Salvador 5
Tashkent 5
Amsterdam 4
Fortaleza 4
Guangzhou 4
Totale 5.645
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 335
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 205
Conformational stability of human erythrocyte transglutaminase. Patterns of thermal unfolding at acid and alkaline pH 202
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 200
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 192
Respiratory Drug Delivery 191
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 189
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity 188
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 187
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 176
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 176
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 175
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 174
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 171
Conformational Aspects of Human Formyl-peptide Receptor Agonists 167
Synthesis and structural characterization of technetium and rhenium complexes containing derivatized amino acids 167
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 166
Conformational aspects of human formylpeptide receptor antagonists 157
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 152
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 149
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 149
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 146
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 142
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 139
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 139
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 137
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: Thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors 136
6-alkyl and 6-arylcarbamoyloximino pyrazolo[3,4-b][1,4]diazepines as potential fungicidal, insecticidal and herbicidal agents 135
Ester recognition by serine proteases. 1. The case of thrombin 134
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 127
Materie Prime: Eccipienti 124
Coniugati dell’acido ascorbico ad attività neurotropica. 124
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 123
Nasal administration and brain targeting of an antiischemic agent 121
Synthesis of a novel series of imidazo[4,5-c]pyrazole derivatives and their evaluation as herbicidal agents 119
New formulation strategies of nanoparticles for the controlled relase of drugs with small or large molecuar weight 119
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 117
Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A(1) receptor ligands 106
Caratterizzazione di potenziali profarmaci di derivati adenosinici ad attività antiischemica. 106
Vitamin C prodrugs of diclophenamic acid: stability studies and uptake analysis on HRPE cells. 104
The recovery method influences properties of adenosine derivatives loaded nanospheres 104
Thermodynamic in vitro studies as a method to investigate the in vivo behaviour of adenosine A1 receptor ligands. 104
Synthesis and characterization of potential adenosine A1 receptor prodrugs 103
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 102
Ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids: design, synthesis and activity 98
Studies for delivery into the brain of neurotropic drugs and their prodrugs conjugated with vitamin C. 97
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 97
Neuropharmaceutical agents and their pro-drug obtained by conjugation with vitamin C: studies of delivery into the brain. 96
Poly(lactic acid) nanoparticles for pro-drug controlled release of N6-cyclopentyl adenosine, an antiischemic agent. 96
Encapsulation modalities of antiischemic adenosine derivatives in poly(lactic acid) nanoparticles. 95
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 95
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C. 91
Improvement of blood brain barrier crossing of drugs by their conjugsation with ascorbic acid. 91
null 91
Development of a spray-dried powder for nasal administration of desmopressin acetate 90
Structure-activity relationships of xanthine antagonists for adenosine A1 and A2A receptors obtained by de novo analysis of binding affinity data. 90
Structure-activity relationships of xanthine antagonists for adenosine A1 and A2A receptors obtained by de novo analysis of binding affinity data 88
null 88
Sintesi e Relazioni Struttura-Attività di 6-ascorbil-derivati da farmaci anti-infiammatori non steroidei 87
Liposomes carrying anti herpetic peptides as a tool for a potential ocular vaccine 87
Poly (lactic acid) microspheres for the sustained release of N6-cyclopentyladenosine 85
Synthesis and study of 5′-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist 84
null 83
Poly(lactic acid) microspheres for the sustained releaseof anttischemic agents. 80
Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine 72
null 48
Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist 43
Totale 8.651
Categoria #
all - tutte 37.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 617
Totale 38.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021444 0 0 0 0 0 70 16 81 11 82 127 57
2021/2022674 11 73 67 67 19 18 21 32 24 51 60 231
2022/2023678 70 33 23 99 136 107 10 54 89 4 32 21
2023/2024338 36 48 11 9 26 63 18 11 3 18 9 86
2024/20251.299 27 30 97 44 177 152 35 56 200 140 188 153
2025/20262.109 435 177 304 580 546 67 0 0 0 0 0 0
Totale 8.651